The pathogenesis of MG is intricately tied to specific autoantibodies that target critical components of the above junction, including acetylcholine receptor (AChR), muscle-specific kinase (MuSK), and lipoprotein receptor-related protein 4 (LRP4) antibodies (1). The gene discussed is LRP4; the disease is myasthenia gravis.